SMART MANUFACTURING Assessment Guiding Pharmaceutical Manufacturers in the Digital Transformation Journey Towards Smart Factory

SMART MANUFACTURING Assessment

Pharma manufacturing industry has many potential areas to improve and establish themselves as leaders in the digital economy.
It’s essential to consider starting early with DX initiatives to secure a strong position within the industry and adapt to future trends.
 
Achieving Pharma4.0 will establish manufacturing capabilities that cater to diverse modalities while ensuring the quality, safety, and efficacy of medicine. This will make these pharmaceuticals, which are currently challenging to mass-produce and costly, more accessible to a larger population.
To realize this, it is crucial to advance digitalization in compliance with pharmaceutical regulatory requirements and integrate equipment with various protocols into one system.
 
Yokogawa will take you through a systematic methodology to find your way in Digital Transformation with Yokogawa Smart Manufacturing (SM) Assessment.
As a leading automation company with a broad range of digital enterprise solutions/products, our expertise with years of experience in pharmaceutical manufacturing industry will develop a Phase-wise Digital Transformation Roadmap that is best fit to achieve customers' business goal.
 
For more information, please see SMART MANUFACTURING Assessment Guiding Pharmaceutical Manufacturers in the Digital Transformation Journey Towards Smart Food Factory.
 

Table of contents

・Future of Pharmaceutical manufacturers
・Accelerating DX in Pharmaceutical Manufacturing
・Digital transformation in Pharmaceutical industry
・Yokogawa Smart Manufacturing (SM) Assessment and value-led Industry 4.0 implementation
    -01 Digital Priority Assessment
    -02 Digital Maturity Assessment
    -03 Develop a Roadmap
・Customer voice
・Yokogawa is your trusted partner for your DX journey
・What Yokogawa foresees as the transition towards future of manufacturing
・Creating a better future, together